Genentech
The Cell Therapy department at Genentech Research and Early Development is seeking a Scientist 3 to advance next-generation, off-the-shelf cell therapies for patients with intractable diseases. This role involves shaping the iPSC-to-T cell differentiation platform, investigating cellular mechanisms, and translating biological discoveries into improvements in cell-product quality and function. The position requires collaboration with cross-functional teams and contributes to scientific and strategic planning for the department and broader therapeutic pipeline.
Headquarters
South San Francisco, California, United States
Company Size
10001+ employees
Founded
1976
Genentech is a research-driven biotechnology company that develops medicines through breakthrough science to treat people with serious and life‑threatening diseases. It discovers, advances and manufactures biologic therapies — including monoclonal antibodies and targeted medicines — across oncology, immunology, neuroscience and other therapeutic areas, moving candidates through discovery and clinical trials. Founded in 1976 and now part of the Roche group, Genentech is known for its patient-centered focus and for translating deep science into transformative, widely used medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genentech.
Scientist/Senior Scientist
ASTARPRD
Postdoctoral Research Fellow
Terasaki Institute for Biomedical Innovation
Senior Scientist, Stem Cell Model Engineering( Contract)
Amgen
Scientist, Cell Line Development
STEMCELL Technologies
Associate Scientist - Cellular Assay Development, Functional Genomics
Amgen
Research Associate or Associate Scientist, Genome Engineer
Conception